Chad Winters
Fortune : 518 941 $ au 31/07/2026
Fortune : 518 941 $ au 31/07/2026
Chad R.
Winters is currently Chief Accounting Officer & VP-Finance at West Pharmaceutical Services, Inc. since 2024.
Former positions include Director at La Causa, Inc. and Controller, Senior VP-Finance & Accounting at Amneal Intermediate, Inc. Education includes an undergraduate degree from Villanova University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 27/04/2026 | 1 522 ( 0 % ) | 518 941 $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| WEST PHARMACEUTICAL SERVICES, INC. | Comptroller/Controller/Auditor | 01/10/2019 |
| Sociétés | Poste | Fin |
|---|---|---|
Amneal Intermediate, Inc.
Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Comptroller/Controller/Auditor | - |
La Causa, Inc.
La Causa, Inc. Services to the Health IndustryHealth Services Provides social services | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. Medical SpecialtiesHealth Technology Manufactures and markets pharmaceuticals, biologics, vaccines & consumer healthcare products | Health Technology |
Villanova University
Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
La Causa, Inc.
La Causa, Inc. Services to the Health IndustryHealth Services Provides social services | Health Services |
Amneal Intermediate, Inc.
Amneal Intermediate, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national